Long-Term Effects of Diesel Exhaust Particles on Airway Inflammation and Remodeling in a Mouse Model

Kim, Byeong-Gon; Lee, Pureun-Haneul; Lee, Shin-Hwa; Kim, Young-En; Shin, Mee-Yong; Kang, Yena; Bae, Seong-Hwan; Kim, Min-Jung; Rhim, TaiYoun; Park, Choon-Sik; Jang, An-Soo

doi:10.4168/aair.2016.8.3.246

Allergy Asthma Immunol Res. 2016 May;8(3):246-256. English.
Published online Nov 16, 2015.
https://doi.org/10.4168/aair.2016.8.3.246

Original Article

Long-Term Effects of Diesel Exhaust Particles on Airway Inflammation and Remodeling in a Mouse Model

Byeong-Gon Kim,¹ Pureun-Haneul Lee,¹ Shin-Hwa Lee,¹ Young-En Kim,¹ Mee-Yong Shin,² Yena Kang,¹ Seong-Hwan Bae,¹ Min-Jung Kim,¹ TaiYoun Rhim,³ Choon-Sik Park,¹ and An-Soo Jang¹

Author information

Author notes

Copyright and License

- ¹Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
- ²Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
- ³Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Korea.
Correspondence to: An Soo Jang, MD, PhD, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital,170 Jomaru-ro, Wonmi-gu, Bucheon 14584, Korea. Tel: +32-621-5143; Fax: +32-621-6950; Email: jas877@schmc.ac.kr

Received April 27, 2015; Revised August 28, 2015; Accepted September 08, 2015.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

Diesel exhaust particles (DEPs) can induce and trigger airway hyperresponsiveness (AHR) and inflammation. The aim of this study was to investigate the effect of long-term DEP exposure on AHR, inflammation, lung fibrosis, and goblet cell hyperplasia in a mouse model.

Methods

BALB/c mice were exposed to DEPs 1 hour a day for 5 days a week for 3 months in a closed-system chamber attached to a ultrasonic nebulizer (low dose: 100 µg/m³ DEPs, high dose: 3 mg/m³ DEPs). The control group was exposed to saline. Enhanced pause was measured as an indicator of AHR. Animals were subjected to whole-body plethysmography and then sacrificed to determine the performance of bronchoalveolar lavage and histology.

Results

AHR was higher in the DEP group than in the control group, and higher in the high-dose DEP than in the low-dose DEP groups at 4, 8, and 12 weeks. The numbers of neutrophils and lymphocytes were higher in the high-dose DEP group than in the low-dose DEP group and control group at 4, 8, and 12 weeks. The levels of interleukin (IL)-5, IL-13, and interferon-γ were higher in the low-dose DEP group than in the control group at 12 weeks. The level of IL-10 was higher in the high-dose DEP group than in the control group at 12 weeks. The level of vascular endothelial growth factor was higher in the low-dose and high-dose DEP groups than in the control group at 12 weeks. The level of IL-6 was higher in the low-dose DEP group than in the control group at 12 weeks. The level of transforming growth factor-β was higher in the high-dose DEP group than in the control group at 4, 8, and 12 weeks. The collagen content and lung fibrosis in lung tissue was higher in the high-dose DEP group at 8 and 12 weeks.

Conclusions

These results suggest that long-term DEP exposure may increase AHR, inflammation, lung fibrosis, and goblet cell hyperplasia in a mouse model.

Keywords

Chronic; diesel exhaust particles; airway remodeling

INTRODUCTION

Air pollutants are believed to be a factor in the increasing prevalence of asthma and to exacerbate respiratory diseases.1 Diesel exhaust particles (DEPs) as a major component of fine particulate matter (PM2.5) in the atmosphere of urban areas can induce airway hyperresponsiveness (AHR) and inflammation by amplifying the T-helper 2 (Th2) immune response2, 3, 4, 5 and are associated with cardiorespiratory mortality and the aggravation of disease.6, 7, 8 DEPs can induce acute AHR and acute asthma exacerbations independent of their effects on allergic sensitization.9

Long-term exposure to air pollution causes chronic respiratory disease,10 and chronic inhalation of DEPs leads to the development of cough and sputum. In addition, chronic bronchitis may be partially responsible for some of the exacerbations of asthma.11 The biological response to inhaled particles is aggravated during chronic exposure to DEPs in a dose-dependent manner. In a previous study, inflammation and overproduction of mucus and surfactant components reached a plateau at 12 or 18 months of exposure during a 24-month experimental period, suggesting that DEPs play an important role in the development of chronic lung injury.12 Airway remodeling in asthma is defined by several structural changes, including epithelial cell mucus metaplasia, an increase in peribronchial smooth muscle mass, subepithelial fibrosis, and angiogenesis. Cytokines, chemokines, and growth factors released from inflammatory and structural cells in the airway are believed to play a pivotal role in the development of remodeling.13, 14, 15, 16 Chronic inflammation is thought to initiate and perpetuate the cycles of tissue injury and repair in asthma, although remodeling may also occur in parallel with inflammation.17

Although long-term, repeated exposure to DEPs in air pollution increases the risk for chronic respiratory diseases and cardiorespiratory mortality,18 the biological mechanism and remodeling remain poorly understood during chronic exposure to DEPs. Therefore, we developed a mouse model of exposure to DEPs, and the effect of long-term exposure to DEPs as one of the air pollutants on airway inflammation and responsiveness, lung fibrosis, and goblet cell hyperplasia was examined.

MATERIALS AND METHODS

DEP sources and preparation

We obtained and used DEPs from Hajime Takizawa. DEPs were collected using the following method. The engine used for preparation of DEPs was a 4JB1 type (Isuzu Automatic Co., Tokyo, Japan), light-duty (2,740-cc), 4-cylinder diesel engine. The engine was connected to an EDGY dynamometer (Meiden-Sya, Tokyo, Japan) and operated using standard diesel fuel with a speed of 1,500 rpm under a load of 10 torque (kg/m). The exhaust was introduced into a stainless steel dilution tunnel (300×8,400 mm) in a constant-volume sampler system equipped to the end of the dilution tunnel. The temperature at the sampling point was below 50℃. The diameter of the particles was measured using an Anderson Air Sampler of the low-pressure type,19 and the mean diameter was 0.4 µm. Most of the shapes analyzed using a scanning electron microscope were globular. Details on the DEPs used were previously described.20, 21

Animal sensitization and exposure conditions

DEPs were sterilized by autoclaving and suspended in serumfree media after coating with BSA to minimize particle aggregation and hydrophobicity.22 After sonication, the endotoxin concentration of the DEP suspension was <0.064 ng/mL (0.32 EU/mL) using the Limulus Amebocyte Lysate assay (QCL-1000; BioWhittaker Inc., Walkersville, MD, USA).23 Female Balb/c mice, 5 to 6 weeks of age and free of mice-specific pathogens, were obtained from Orient Co, Ltd (Charles River Laboratories, Seoul, Korea). The mice were housed throughout the experiments in a laminar flow cabinet and maintained on standard laboratory chow ad libitum. All experimental animals used in this study were treated according to guidelines approved by the Institutional Animal Care and Use Committee of the Soonchunhyang University Medical School. DEPs were resuspended in saline solution for 30 minutes before administration. The mice (n=8 in each group) were exposed to 100 µg/m³ and 3 mg/m³ DEPs for 1 hour a day for 5 days a week from 4 to 12 weeks (Fig. 1) in a closed-system chamber attached to an ultrasonic nebulizer (NE-UO7; Omron Corporation, Tokyo, Japan) with an output of 1 mL/min and 1- to 5-µm particle size.

Fig. 1
Schematic diagram of the experimental protocol. Mice were exposed to DEPs 5 days a week for 3 months and either 100 µg/m³ or 3 mg/m³ DEPs (or saline as a control) using an ultrasonic nebulizer.

The control mice were administered and exposed to saline solution alone. Mice were sacrificed with an overdose of pentobarbital sodium (65 mg/kg body weight, administered intraperitoneally). The chest cavity was exposed, and the catheter was carefully inserted into the trachea and secured with ligatures. Bronchoalveolar lavage (BAL) was performed by 4 instillations of 1 mL of normal saline and gentle retrieval. Cell numbers were measured using a hemocytometer, and differential cell counts were performed on slides prepared by cyto-centrifugation and Diff-Quik staining (Scientific Products, Gibbstowne, NJ, USA). Supernatants were separated by centrifugation (500 g, 5 minutes) and maintained at -70℃ until use. After ligation of the right main bronchus, the left lung was fixed with 4% paraformaldehyde in phosphate-buffered saline and paraffin-embedded. The right lung was excised and immersed in TRI reagent (guanidinium thiocyanate-phenol mixture; Molecular Research Center Inc., Cincinnati, OH, USA), and immediately frozen in liquid nitrogen.

Determination of airway responsiveness to methacholine

Airway responsiveness was measured in unrestrained, conscious mice 1 day after the last challenge, as previously described.24 Mice were placed in a barometric plethysmographic chamber (All Medicus Co., Seoul, Korea), and baseline readings were taken and averaged for 3 minutes. Aerosolized methacholine in increasing concentrations (from 2.5 to 50 mg/mL was nebulized through an inlet of the main chamber for 3 minutes. Readings were taken and averaged for 3 minutes after each nebulization, at which time the enhanced pause (Penh) was determined. Penh, calculated as (expiratory time/relaxation time - 1)×(peak expiratory flow/peak inspiratory flow) according to the manufacturers' protocol, is a dimensionless value that represents the proportion of maximal expiratory to maximal inspiratory box pressure signals and the timing of expiration. Penh is used as a measure of airway responsiveness to methacholine. The results are expressed as the percentage increase of Penh following challenge with each concentration of methacholine, where the baseline Penh (after saline challenge) is expressed as 100%. Penh values averaged for 3 minutes after each nebulization were evaluated.

Preparation of lung tissues for histology and immunohistochemistry

Trachea and lung tissues were removed from the rats. Four percent paraformaldehyde fixing solution was infused into the lungs via the trachea. The specimens were dehydrated and embedded in paraffin. For histological examination, 4-µm sections of embedded tissue were cut on a rotary microtome, placed on glass slides, deparaffinized, and stained sequentially with hematoxylin and eosin.

Measurement of cytokine levels in BAL fluids

The cytokine levels were quantified in BAL fluid using a sandwich enzyme-linked immunosorbent assay kit according to the manufacturer's protocol (Biosource International Inc., Camarillo, CA, USA). Each sample was determined in triplicate. The lower limit of detection for interleukin (IL)-5, IL-13, interferon (IFN)-γ, IL-10, and vascular endothelial growth factor (VEGF) was 0.17, 30.00, 14.70, 15.60, and 2.00 pg/mL, respectively. Values below these limits were considered zero for statistical analysis. Inter- and intra-assay coefficients of variance were <10%.

Collagen assay

Collagen assays were performed according to the user manual of the Sircol collagen assay kit (Biocolor, Northern Ireland, UK). Briefly, 100 µL of the protein extract sample in lung tissue was mixed with 1 mL of Sircol dye for 30 minutes and centrifuged at 10,000 rpm for 5 minutes to precipitate the formed collagen-dye complex. After decanting the suspension, droplets were dissolved in 1 mL of Sircol alkali reagent and vortexed. A total of 100 µl of the acquired solution was read at 540 nm.

Masson trichrome assay

The lung tissue slides were placed under a warmer at 60℃ for 30 minutes. Next, samples were immersed in xylene for 15 minutes, followed by 100%, 95%, 90%, 80%, and 70% ethanol for 10 minutes each. The slides were stained in accordance with the manual of the Masson trichrome assay kit (Sigma-Aldrich, St. Louis MO, USA). Briefly, Bouin's solution was used as a mordant to intensify the color reactions. The nucleus and cytoplasm were dyed using hematoxylin and scarlet acid. Phosphotungstic/phosphomolybdic acid solution was used to change a positive to a negative charge. After staining with aniline blue, the samples were treated with 1% acetic acid. Prior to observation, the samples were mounted with a cover slip using mounting media (Amresco, OH, USA). The positive trichrome-stained area was quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Values are reported as a percentage of positive areas within the total sample.

Periodic acid-Schiff assay

The slides were stained in accordance with the manual of a periodic acid-Schiff assay kit (Abcam, Cambridge, MA, USA). Briefly, lung tissue was cut into 4-µm sections and placed in periodic acid solution for 5 minutes. After washing with distilled water, the specimens were immersed in Schiff's fluid for 15 minutes. The slides were again washed with distilled water for 5 minutes and then placed in hematoxylin for 3 minutes. After the slides were exposed to running tap water for 3 minutes, bluing reagent was applied for 30 seconds. Before observation, the slides were mounted with a cover slip using mounting media (Amresco).

Statistical analysis

Differences between independent samples were compared using the nonparametric Kruskal-Wallis H test for continuous data. If differences were found to be significant, the Mann-Whitney U test was applied to compare differences between 2 samples. Differences were considered significant when a P value was <0.05. Results are expressed as mean±standard error of the mean (SEM) unless otherwise stated.

RESULTS

Airway responsiveness was measured 4, 8, and 12 weeks after the last exposure to DEPs in mice (Fig. 1). Airway responsiveness to aerosolized methacholine was measured in unrestrained, conscious mice. Mice were placed in the main chamber with a barometric plethysmograph and nebulized first with saline and then with increasing doses (from 2.5 to 100.0 mg/mL) of methacholine for 3 minutes for each nebulization. Readings of breathing parameters were taken for 3 minutes after each nebulization, during which time Penh values were determined. AHR was higher in the low-dose and high-dose DEP groups than in the control group and higher in the high-dose DEP group than in the low-dose DEP group at 4, 8, and 12 weeks (Fig. 2).

Fig. 2
Effect of DEP exposure on airway responsiveness in mice. ^**P<0.01 vs the sham group; ^†P<0.01 vs the sham group; ^‡P<0.01 vs the low-dose DEP group.

The total cell count in the BAL fluid tended to be higher in the low-dose DEP group than in the control group at 4, 8, and 12 weeks, and there was a significant increase in the total cell count in the high-dose DEP group than in the control group at 4 weeks (P<0.05) (Fig. 3). There were no differences in the number of macrophages among the 3 groups. The number of neutrophils was larger in the high-dose DEP group than in the control group at 4, 8, and 12 weeks (P<0.05 for each) (Fig. 3). The number of lymphocytes was larger in the high-dose DEP group than in the control group at 4, 8, and 12 weeks (P<0.05).

Fig. 3
Changes in cell profiles in bronchioalveolar lavage fluid. ^*P<0.05 vs the control group; ^**P<0.01 vs the control group.

The level of IL-5 was higher in the low-dose DEP group than in the control group at 12 weeks (Fig. 4). The level of IL-13 was higher in the low- and high-dose DEP groups than in the control group at 12 weeks (Fig. 4). The level of IFN-γ was higher in the low-dose DEP group than in the control group at 12 weeks (Fig. 5). The level of IL-10 was higher in the high-dose DEP group than in the control group at 12 weeks (Fig. 6). The level of VEGF was higher in the low- and high-dose DEP groups than in the control group at 12 weeks (Fig. 7). The level of IL-6 was higher in the low-dose DEP group than in the control group at 12 weeks (Fig. 8A). The level of transforming growth factor-β (TGF-β) was higher in the high-dose DEP group than in the control group at 4, 8, and 12 weeks (Fig. 8B).

Fig. 4
Effect of DEPs on IL-5 and IL-13 levels in BAL fluid. Bars represent mean±SEM from the 6 independent experiments. ^*P<0.05 vs the sham group.

Fig. 5
Effect of DEP on IFN-γ level in BAL fluid. Bars represent mean±SEM from the 6 independent experiments. ^*P<0.05 vs the sham group.

Fig. 6
Effect of DEP on IL-10 level in BAL fluid. Bars represent mean±SEM from the 6 independent experiments. ^*P<0.05 vs the sham group.

Fig. 7
Effect of DEP on VEGF level in BAL fluid. Bars represent mean±SEM from the 6 independent experiments. ^*P<0.05 vs the sham group.

Fig. 8
Effect of DEP on IL-6 (A) and TGF-β (B) levels in BAL fluid. Bars represent mean±SEM from the 6 independent experiments. ^*P<0.05 vs the sham group.

Lung fibrosis as shown by Masson trichrome staining of lung tissues was more severe in the low- and high-dose DEP groups than in the control group (Fig. 9A and B). The collagen content in lung tissues was greater in the high-dose DEP group than in the control group at 8 and 12 weeks (P<0.05) (Fig. 9C). Goblet cell hyperplasia in lung tissues was more severe in the high-dose DEP group than in the control group at 8 and 12 weeks (Fig. 10).

Fig. 9
Lung fibrosis as shown by (A) Masson trichrome staining, (B) % area, and (C) collagen content. ^*P<0.05 vs the control group.

Fig. 10
Goblet cell hyperplasia in the lung based on periodic acid-Schiff staining.

DISCUSSION

This study revealed that long-term exposure to DEP leads to increased airway responsiveness and inflammatory cell infiltration, cytokine changes, collagen deposition, and goblet cell hyperplasia, indicating that long-term exposure to DEPs may be associated with AHR, inflammation, and lung fibrosis.

DEPs are the particulate component of diesel exhaust, which includes diesel soot and aerosols, such as ash particulates, metallic abrasion particles, sulfates, and silicates.25 Exposure to DEPs has been associated with acute short-term symptoms, such as headache, dizziness, light-headedness, nausea, coughing, difficult or labored breathing, chest tightness, and irritation of the eyes, nose, and throat.25 DEPs are related to allergic diseases, including asthma and allergic rhinitis based on extensive epidemiological studies25, 26, 27 and act as an adjuvant during allergen exposure and effect acute asthma exacerbations, bronchitis, or chronic obstructive pulmonary disease.28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38 Previous research has shown a strong link between particulate air pollution and detrimental health effects, including cardiopulmonary morbidity and mortality.39 In this study, AHR was higher in the low- and high-dose DEP groups than in the control group and higher in the high-dose DEP group than in the low-dose DEP group at 4, 8, and 12 weeks, suggesting that DEPs can induce AHR in a dose-dependent manner.

DEP exposure is associated with asthma and airway cell apoptosis. DEPs may directly contribute to asthma by inducing epithelial cell death through the apoptotic pathway40 and inducing inflammatory responses in human airway epithelial cells.41 DEPs activate intracellular signaling pathways that culminate in the production of profibrotic cytokines and growth factors.38 DEPs activate T cells in asthmatics with a higher effect during exacerbations, suggesting that uncontrolled asthma is a risk factor for aggravation in individuals exposed to traffic pollutants.42 DEPs also induce time-dependent increases in IL-8, granulocyte-macrophage colony-stimulating factor, and IL-1β in epithelial cell lines.42 DEPs affect dendritic cells (DCs), which results in increased production of TNF, IL-6, IFN-γ, IL-12, and VEGF.41 In costimulation assays of PM-exposed DCs and alloreactive CD4+ T cells, DEPs directed a Th2-like pattern of cytokine production (e.g., enhanced production of IL-13 and IL-18, and suppressed of production IFN-γ).43 Pro-oxidative DEP chemicals can interfere with Th1-promoting response pathways in a homogeneous DC population and provide a novel explanation for the adjuvant effect of DEPs on allergic inflammation, indicative of an adjuvant effect of particulate air pollutants in allergic inflammatory disease.44 DEPs induce antigen-independent DC maturation via epithelial cell-DC interactions mediated by the human bronchial epithelial cell-derived granulocyte-macrophage colony-stimulating factor.45 In our study, IL-6 and TGF-β were increased in the DEP long-term exposure group, suggesting that Th17 cytokine may be involved in airway inflammation following DEP exposure. Alveolar macrophages play an important role in particle-induced lung inflammation via direct induction of IL-13 production, suggesting that alveolar macrophages may act as major effectors of innate immunity to modulate immune and inflammatory responses toward a Th2-like condition via the production of IL-13, as observed in the adaptive immune response.46 In our study, IL-5, IL-13, INF-γ, and IL-10 were increased in the DEP long-term exposure group, suggesting that Th2, Th1, and regulatory cytokines are involved in airway inflammation following DEP exposure. In addition, DEP exposure has been associated with the upregulation of allergic immune responses and airway remodeling in both animal and human studies.47, 48 Long-term exposure can lead to serious chronic health problems, such as cardiovascular disease, cardiopulmonary disease, and lung cancer.35 Fibrotic reactions are a component of these pulmonary diseases and are involved in the progressive deposition of collagen by pulmonary fibroblasts.38 In this study, lung fibrosis, the collagen content, and VEGF in mice lungs exposed to long-term DEPs in a dose-dependent manner indicated that chronic exposure to DEPs can play a role in airway remodeling and angiogenesis. In addition, exposure to a higher dose of DEPs leads to increased airway inflammation, a higher cytokine response, and more severe lung fibrosis, suggesting that environmental reduction of DEP exposure is important for patients with airway diseases. In conclusion, chronic exposure to DEPs can cause AHR, inflammation, goblet cell hyperplasia, and lung fibrosis.

Notes

There are no financial or other issues that might lead to conflict of interest.

ACKNOWLEDGMENTS

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2013R1A1A2005465) and Soonchunhyang University Research Fund.

References

1. Brandt EB, Biagini Myers JM, Acciani TH, Ryan PH, Sivaprasad U, Ruff B, et al. Exposure to allergen and diesel exhaust particles potentiates secondary allergen-specific memory responses, promoting asthma susceptibility. J Allergy Clin Immunol 2015;136:295–303.e7.
  PubMed
  
  CrossRef
1. Inoue K, Tanaka M, Takano H. DEP-induced T(H)17 response in asthmatic subjects. J Allergy Clin Immunol 2014;133:1495–1496. 1496.e1.
  PubMed
  
  CrossRef
1. Folinsbee LJ. Human health effects of air pollution. Environ Health Perspect 1993;100:45–56.
  PubMed
  
  CrossRef
1. Acciani TH, Brandt EB, Khurana Hershey GK, Le Cras TD. Diesel exhaust particle exposure increases severity of allergic asthma in young mice. Clin Exp Allergy 2013;43:1406–1418.
  PubMed
  
  CrossRef
1. Saito Y, Azuma A, Kudo S, Takizawa H, Sugawara I. Long-term inhalation of diesel exhaust affects cytokine expression in murine lung tissues: comparison between low- and high-dose diesel exhaust exposure. Exp Lung Res 2002;28:493–506.
  PubMed
  
  CrossRef
1. Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:1753–1759.
  PubMed
  
  CrossRef
1. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 2000;343:1742–1749.
  PubMed
  
  CrossRef
1. Hoek G, Brunekreef B, Goldbohm S, Fischer P, van den Brandt PA. Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet 2002;360:1203–1209.
  PubMed
  
  CrossRef
1. Hao M, Comier S, Wang M, Lee JJ, Nel A. Diesel exhaust particles exert acute effects on airway inflammation and function in murine allergen provocation models. J Allergy Clin Immunol 2003;112:905–914.
  PubMed
  
  CrossRef
1. Pope CA, Dockery DW, Schwartz J. Review of epidemiological evidence of health effects of particulate air pollution. Inhal Toxicol 1995;7:1–18.
  CrossRef
1. Morgan WK, Reger RB, Tucker DM. Health effects of diesel emissions. Ann Occup Hyg 1997;41:643–658.
  PubMed
  
  CrossRef
1. Ishihara Y, Kagawa J. Chronic diesel exhaust exposures of rats demonstrate concentration and time-dependent effects on pulmonary inflammation. Inhal Toxicol 2003;15:473–492.
  PubMed
  
  CrossRef
1. Ghio AJ, Smith CB, Madden MC. Diesel exhaust particles and airway inflammation. Curr Opin Pulm Med 2012;18:144–150.
  PubMed
  
  CrossRef
1. Royce SG, Moodley Y, Samuel CS. Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Pharmacol Ther 2014;141:250–260.
  PubMed
  
  CrossRef
1. van den Brûle S, Heymans J, Havaux X, Renauld JC, Lison D, Huaux F, et al. Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am J Respir Cell Mol Biol 2007;37:202–209.
  CrossRef
1. Henderson WR Jr, Chi EY, Bollinger JG, Tien YT, Ye X, Castelli L, et al. Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 2007;204:865–877.
  PubMed
  
  CrossRef
1. Kunzmann S, Schmidt-Weber C, Zingg JM, Azzi A, Kramer BW, Blaser K, et al. Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: potential role of histamine in airway remodeling. J Allergy Clin Immunol 2007;119:1398–1407.
  PubMed
  
  CrossRef
1. Sydbom A, Blomberg A, Parnia S, Stenfors N, Sandström T, Dahlén SE. Health effects of diesel exhaust emissions. Eur Respir J 2001;17:733–746.
  PubMed
  
  CrossRef
1. Andersen AA. A sampler for respiratory health hazard assessment. Am Ind Hyg Assoc J 1966;27:160–165.
  PubMed
  
  CrossRef
1. Song HM, Jang AS, Ahn MH, Takizawa H, Lee SH, Kwon JH, et al. Ym1 and Ym2 expression in a mouse model exposed to diesel exhaust particles. Environ Toxicol 2008;23:110–116.
  PubMed
  
  CrossRef
1. Lee GB, Brandt EB, Xiao C, Gibson AM, Le Cras TD, Brown LA, et al. Diesel exhaust particles induce cysteine oxidation and s-glutathionylation in house dust mite induced murine asthma. PLoS One 2013;8:e60632.
  PubMed
  
  CrossRef
1. Kim J, Natarajan S, Vaickus LJ, Bouchard JC, Beal D, Cruikshank WW, et al. Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines. Am J Pathol 2011;179:2730–2739.
  PubMed
  
  CrossRef
1. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261–2263.
  CrossRef
1. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766–775.
  PubMed
  
  CrossRef
1. Diaz-Sanchez D, Proietti L, Polosa R. Diesel fumes and the rising prevalence of atopy: an urban legend? Curr Allergy Asthma Rep 2003;3:146–152.
  PubMed
  
  CrossRef
1. Jung DY, Leem JH, Kim HC, Kim JH, Hwang SS, Lee JY, et al. Effect of traffic-related air pollution on allergic disease: results of the children's health and environmental research. Allergy Asthma Immunol Res 2015;7:359–366.
  PubMed
  
  CrossRef
1. Lee JH, Lee HS, Park MR, Lee SW, Kim EH, Cho JB, et al. Relationship between indoor air pollutant levels and residential environment in children with atopic dermatitis. Allergy Asthma Immunol Res 2014;6:517–524.
  PubMed
  
  CrossRef
1. Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A. Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol 1998;102:539–554.
  PubMed
  
  CrossRef
1. Takahashi G, Tanaka H, Wakahara K, Nasu R, Hashimoto M, Miyoshi K, et al. Effect of diesel exhaust particles on house dust mite-induced airway eosinophilic inflammation and remodeling in mice. J Pharmacol Sci 2010;112:192–202.
  PubMed
  
  CrossRef
1. Takano H, Ichinose T, Miyabara Y, Yoshikawa T, Sagai M. Diesel exhaust particles enhance airway responsiveness following allergen exposure in mice. Immunopharmacol Immunotoxicol 1998;20:329–336.
  PubMed
  
  CrossRef
1. Ohta K, Yamashita N, Tajima M, Miyasaka T, Nakano J, Nakajima M, et al. Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF. J Allergy Clin Immunol 1999;104:1024–1030.
  PubMed
  
  CrossRef
1. Ichinose T, Takano H, Miyabara Y, Sadakaneo K, Sagai M, Shibamoto T. Enhancement of antigen-induced eosinophilic inflammation in the airways of mast-cell deficient mice by diesel exhaust particles. Toxicology 2002;180:293–301.
  PubMed
  
  CrossRef
1. Walters DM, Breysse PN, Wills-Karp M. Ambient urban Baltimore particulate-induced airway hyperresponsiveness and inflammation in mice. Am J Respir Crit Care Med 2001;164:1438–1443.
  PubMed
  
  CrossRef
1. Miyabara Y, Ichinose T, Takano H, Lim HB, Sagai M. Effects of diesel exhaust on allergic airway inflammation in mice. J Allergy Clin Immunol 1998;102:805–812.
  PubMed
  
  CrossRef
1. Lim HB, Ichinose T, Miyabara Y, Takano H, Kumagai Y, Shimojyo N, et al. Involvement of superoxide and nitric oxide on airway inflammation and hyperresponsiveness induced by diesel exhaust particles in mice. Free Radic Biol Med 1998;25:635–644.
  PubMed
  
  CrossRef
1. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 1997;156:36–42.
  PubMed
  
  CrossRef
1. Monforton C. Weight of the evidence or wait for the evidence? Protecting underground miners from diesel particulate matter. Am J Public Health 2006;96:271–276.
  PubMed
  
  CrossRef
1. Bonner JC. Lung fibrotic responses to particle exposure. Toxicol Pathol 2007;35:148–153.
  PubMed
  
  CrossRef
1. Riedl M, Diaz-Sanchez D. Biology of diesel exhaust effects on respiratory function. J Allergy Clin Immunol 2005;115:221–228.
  PubMed
  
  CrossRef
1. Ackland ML, Zou L, Freestone D, van de Waasenburg S, Michalczyk AA. Diesel exhaust particulate matter induces multinucleate cells and zinc transporter-dependent apoptosis in human airway cells. Immunol Cell Biol 2007;85:617–622.
  PubMed
  
  CrossRef
1. Cao D, Bromberg PA, Samet JM. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. Am J Respir Cell Mol Biol 2007;37:232–239.
  PubMed
  
  CrossRef
1. Mamessier E, Nieves A, Vervloet D, Magnan A. Diesel exhaust particles enhance T-cell activation in severe asthmatics. Allergy 2006;61:581–588.
  PubMed
  
  CrossRef
1. Porter M, Karp M, Killedar S, Bauer SM, Guo J, Williams D, et al. Diesel-enriched particulate matter functionally activates human dendritic cells. Am J Respir Cell Mol Biol 2007;37:706–719.
  PubMed
  
  CrossRef
1. Chan RC, Wang M, Li N, Yanagawa Y, Onoé K, Lee JJ, et al. Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation. J Allergy Clin Immunol 2006;118:455–465.
  PubMed
  
  CrossRef
1. Bleck B, Tse DB, Jaspers I, Curotto de Lafaille MA, Reibman J. Diesel exhaust particle-exposed human bronchial epithelial cells induce dendritic cell maturation. J Immunol 2006;176:7431–7437.
  PubMed
  
  CrossRef
1. Kang CM, Jang AS, Ahn MH, Shin JA, Kim JH, Choi YS, et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 2005;33:290–296.
  PubMed
  
  CrossRef
1. Nordling E, Berglind N, Melén E, Emenius G, Hallberg J, Nyberg F, et al. Traffic-related air pollution and childhood respiratory symptoms, function and allergies. Epidemiology 2008;19:401–408.
  PubMed
  
  CrossRef
1. Dai J, Xie C, Vincent R, Churg A. Air pollution particles produce airway wall remodeling in rat tracheal explants. Am J Respir Cell Mol Biol 2003;29:352–358.
  PubMed
  
  CrossRef